SwePub
Sök i SwePub databas

  Extended search

AND is the default operator and can be omitted

Träfflista för sökning "AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Clinical Laboratory Medicine) srt2:(1995-1999)"

Search: AMNE:(MEDICAL AND HEALTH SCIENCES Clinical Medicine Clinical Laboratory Medicine) > (1995-1999)

  • Result 1-10 of 33
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Johannsson, Gudmundur, 1960, et al. (author)
  • Serum leptin concentration and insulin sensitivity in men with abdominal obesity.
  • 1998
  • In: Obesity research. - 1071-7323. ; 6:6, s. 416-21
  • Journal article (peer-reviewed)abstract
    • We have examined the association between generalized adiposity, abdominal adiposity, insulin sensitivity, and serum levels of leptin in a cross-sectional study of abdominally obese men.Thirty men, 48 to 66 years of age with a body mass index (BMI) of between 25 kg/m2 and 35 kg/m2 and a waist hip ratio of >0.95, were included in the study. Serum leptin concentration was measured using radioimmunoassay. Total body fat percentage was determined from total body potassium, abdominal adiposity was measured by computed tomography, and the glucose disposal rate (GDR) was measured during an euglycemic, hyperinsulinemic glucose clamp.Significant correlations were found between serum leptin concentration and BMI, percentage body fat, abdominal subcutaneous adipose tissue, serum insulin, GDR, and 24-hour urinary-free cortisol. In a multiple regression analysis, it was shown that abdominal subcutaneous adipose tissue, GDR, and BMI explained 72% of the variability of serum leptin concentration. GDR demonstrated an independent inverse correlation with serum leptin concentration.In abdominally obese men with insulin resistance, it was demonstrated that most of the individual variability in serum leptin concentration was explained by the amount of subcutaneous abdominal adipose tissue, insulin sensitivity, and BMI.
  •  
2.
  • Sriplakich, S., et al. (author)
  • Epidermal growth factor receptor expression : predictive value for the outcome after cystectomy for bladder cancer?
  • 1999
  • In: BJU International. - Oxon, United Kingdom : Blackwell Publishing. - 1464-4096 .- 1464-410X. ; 83:4, s. 498-503
  • Journal article (peer-reviewed)abstract
    • Objective: To determine whether epidermal growth factor receptor (EGFR) immunostaining of tumour cells is associated with cancer-specific death after cystectomy for locally advanced bladder cancer.Patients and Methods: The hospital records of all patients treated with cystectomy for urothelial cancer of the urinary bladder between 1967 and 1992 were reviewed retrospectively. The paraffin-embedded specimens obtained before treatment from 173 patients were processed for immunohistochemical staining, using the monoclonal antibody NCL-EGFR (Novocastra, UK). EGFR immunostaining was considered positive if membrane staining was found in at > or = 20% of tumour cells in one or more fields at > or = 200 (area 0.59 mm2).Results: Most patients (149) received preoperative irradiation and one had neoadjuvant chemotherapy. The mean observation time was 81.3 months; 63 patients (36%) had tumour recurrence within 1-80 months (mean 18.3). Positive EGFR immunostaining was found in 100 patients (58%). The proportion of T2-4 tumours was higher in those EGFR-positive than in those EGFR-negative. Proportional-hazards analysis revealed that clinical stage was significantly associated with cancer-specific death, but EGFR expression was not.Conclusion: Although positive immunostaining for EGFR was more frequent in higher stages of locally advanced bladder cancer, this variable was not an independent predictor of outcome after cystectomy.
  •  
3.
  • Lindstedt, Göran, 1937, et al. (author)
  • [How reliable is the laboratory? Increased needs of patient-related quality assurance]. : Kan man lita på laboratoriet? Okat behov av patientrelaterad kvalitetssäkring. Expertgruppen för endokrinologi inom EQUALIS.
  • 1999
  • In: Läkartidningen. - 0023-7205. ; 96:38, s. 4028-31
  • Journal article (peer-reviewed)abstract
    • Recent developments in medical care and research involve the increased use of immunochemical assays for hormones, tumour markers, vitamins and drugs. External quality assurance programmes using pooled human sera usually fail to detect analytical interference due to substances (e.g. anti-immunoglobulin or anti-ligand antibodies) present in individual serum specimens. The article reports on experience gained during a three-year period when specimens from individual patients attending a thyroid unit were distributed to hospital laboratories in Sweden for analysis. Specimen selection criteria were based on contradictory findings at the initial clinical or laboratory evaluation. The programme has given rise to the formation of a network of the laboratories involved, under the co-ordination of EQUALIS (External quality assurance in laboratory medicine in Sweden).
  •  
4.
  • Brandberg, Joakim, et al. (author)
  • Increased accuracy of echocardiographic measurement of flow using automated spherical integration of multiple plane velocity vectors
  • 1999
  • In: Ultrasound in Medicine and Biology. - 0301-5629 .- 1879-291X. ; 25:2, s. 249-257
  • Journal article (peer-reviewed)abstract
    • The calculation of blood flow in the heart by surface integration of velocity vectors (SIVV) using Doppler ultrasound is independent of the angle. Flow is normally calculated from velocity in a spherical thick shell with its center located at the ultrasound transducer. In a numerical simulation, we have shown that the ratio between minor and major axes of an elliptic flow area substantially influences the accuracy of the estimation of flow in a single scan plane. The accuracy of flow measurements by SIVV can be improved by calculating the mean of the values from more than one scan plane. We have produced an automated computer program that includes an antialiasing procedure. We confirmed an improvement of flow measurements in a pulsatile hydraulic flow model, the 95% confidence interval for single estimations being reduced from 20% to 10% (p < 0.05) using the newly developed software. We think that the SIVV method has important implications for clinical transthoracic echocardiography.
  •  
5.
  •  
6.
  • Davidsson, Åke, 1956-, et al. (author)
  • Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Clinical relevance and relation to allergy
  • 1996
  • In: Acta Oto-Laryngologica. - Oxfordshire, United Kingdom : Taylor & Francis. - 0001-6489 .- 1651-2251. ; 116:4, s. 604-610
  • Journal article (peer-reviewed)abstract
    • Interleukins 6 (IL-6) and 12 (IL-12), and the chemoattractant chemokine RANTES were studied in ethmoidal mucosa, using reverse transcriptase polymerase chain reaction. The 49 patients had chronic sinusitis or nasal/paranasal polyposis, and some also allergy. To the best of our knowledge, this is the first study that demonstrates RANTES and IL-12 on mRNA level in human sinonasal mucosa in situ. mRNA for IL-6, IL-12 and RANTES were detected in 2, 8 and 6 patients with chronic sinusitis, respectively, and in mucosa from patients with polyposis a positive expression was observed in 4, 14 and 10 cases. There were no statistically significant differences. Analysing the entire group of 49 patients, disregarding type of mucosal disease, the number of patients with positive RANTES was significantly higher than that for IL-6. Similarly, IL-12 positivity was more frequently expressed than IL-6. mRNA for IL-6 was expressed in only 2 of the allergic patients. The cytokine production studied thus seems to be unrelated to the clinically defined entities. There is thus a local production in human diseased sinonasal mucosa of RANTES, as well as of IL-6 and IL-12. The local production of RANTES is an important prerequisite for recruitment and migration of inflammatory cells into the tissue. IL-12 is a co-stimulator of antigen-specific responses of established T helper 1 (Th1) clones, and regulates the responsiveness of the clones to a number of T cell growth factors. The study supports a shift towards Th1 cells in these disease entities.
  •  
7.
  • Karlsson, Mats G., 1960-, et al. (author)
  • Endothelial adhesion molecules for nasal-homing T cells in allergy
  • 1996
  • In: Virchows Archiv. - Heidelberg, Germany : Springer. - 0945-6317 .- 1432-2307. ; 429:1, s. 49-54
  • Journal article (peer-reviewed)abstract
    • During the allergic reaction mucosal T cells are activated and a local increase in numbers occurs. In peripheral blood, a concomitant T cell activation and switch towards memory phenotype appears. E-selectin, intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 were studied in nasal mucosal biopsies taken during a time-course provocation study, including patients with seasonal allergic rhinitis and healthy controls. Allergic patients were also studied during the natural pollen season with particular attention to the influence of local corticosteroid treatment. Before provocation allergic patients and controls did not differ concerning the expression of endothelial adhesion molecules. However, the epithelial ICAM-1 expression was increased among allergics (P < 0.05). Repetitive allergen provocation induces an increased endothelial expression of VCAM-1 in allergic patients (P < 0.01). Similarly, VCAM-1 expression was increased during the natural pollen season (P < 0.05). Interestingly, the increased VCAM-1 expression was inhibited by the use of local corticosteroids. The present data demonstrate a putative integrin-VCAM-1 mechanism for selective homing of T memory cells to the allergic nasal mucosa and new in vivo effects of local corticosteroid treatment are demonstrated.
  •  
8.
  • Karlsson, Mats G., 1960-, et al. (author)
  • Nasal messenger RNA expression of interleukins 2, 4, and 5 in patients with allergic rhinitis
  • 1995
  • In: Diagnostic molecular pathology (Print). - Philadelphia, USA : Lippincott Williams & Wilkins. - 1052-9551 .- 1533-4066. ; 4:2, s. 85-92
  • Journal article (peer-reviewed)abstract
    • In nasal biopsies from 17 adult patients with seasonal allergic rhinitis and from 10 healthy controls, cytokines were analyzed by reverse-transcriptase polymerase chain reaction (RT-PCR). The time-course study during winter included repeated local allergen provocation with subsequent nasal biopsies as well as biopsies taken during pollen season. The RT-PCR for CD44 yielded positive bands in 65 of 71 cases, in which cases mRNA for interleukins 2, 4, and 5 (IL-2, IL-4, and IL-5) were thus investigated by means of seminested PCR. IL-4 mRNA was found almost exclusively in the allergic patients. During provocation a significant increase in IL-4 was noticed compared with controls (p = 0.043). Equally, during the natural pollen season, IL-4 mRNA expression was significantly higher in patients not using nasal corticosteroids compared with those who did (p = 0.011). No differences in IL-2 or IL-5 were observed between the groups. These findings also indicate, together with earlier observations of T-cell activation, a phenotype switch toward T-helper 2 (Th2) cells, and the accumulation (homing) of these T cells in the nasal mucosa, that T cells constitute the main source for IL-4 in the nasal mucosa. Therefore, allergic patients have an increased synthesis of IL-4 when provoked with the allergen, and during natural pollen season this synthesis can be downregulated by corticosteroids. Furthermore, this study exemplifies the versatility of molecular biology in surgical pathology and that even low-copy-number cytokine mRNA can be examined in routinely snap-frozen surgical specimens.
  •  
9.
  •  
10.
  • Boguszewski, C L, et al. (author)
  • Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.
  • 1997
  • In: The Journal of clinical endocrinology and metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 82:5, s. 1516-21
  • Journal article (peer-reviewed)abstract
    • GH represents several molecular isoforms in addition to the main 22-kDa (22K) GH. There have been reports suggesting that circulating non-22K GH isoforms are increased in acromegaly, but the possible implications of such observations in the management of the disease have not been addressed. The aim of this study was to evaluate the proportion of circulating non-22K GH isoforms in acromegaly. In addition, the relationships between the amount of non-22K GH and tumor size, biochemical measurements, and body composition also were investigated. Samples with different GH levels were selected from 24-h GH profiles from 15 acromegalic men evaluated before and 1 yr after transsphenoidal surgery and from 13 healthy men. The serum non-22K GH levels, expressed as percentage of total GH concentration, were determined by the 22K GH exclusion assay, which is based on immunomagnetic extraction of 22K GH from serum and quantitation of non-22K GH using a polyclonal GH assay. The proportion of non-22K GH isoforms was fairly constant in different samples from the same patient, regardless of the GH level. However, a wide variation of values was observed among acromegalics, both before (14-51%) and after surgery (8-62%). The proportion of non-22K GH isoforms was increased in untreated patients, compared with controls (26.6 vs. 17.4%; P < 0.01), and the values correlated significantly to tumor size, mean 24-h GH concentration, serum PRL, and extracellular water. After surgery, patients not truly cured, with mean 24-h GH concentration of 1 microg/L or more, had an increased proportion of non-22K GH, compared with those with levels less than 1 microg/L (P < 0.01). In the former group, the median values were similar than those in untreated acromegalics (34 vs. 26.6%, respectively), whereas in the latter, they were comparable with those in the controls (15.2 vs. 17.4%, respectively). We conclude that acromegalics have an increased proportion of circulating non-22K GH isoforms. The values are fairly constant in different samples from an individual, regardless of GH level, but a large spectrum can be observed among patients. This variability suggests that different pituitary adenomas secrete GH isoforms in variable amounts. Our observation that a higher proportion of non-22K GH isoforms is present in patients not truly cured after surgery suggests that the evaluation of non-22K GH isoforms can be useful in the follow-up of acromegalic patients.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-10 of 33
Type of publication
journal article (32)
book chapter (1)
Type of content
peer-reviewed (32)
other academic/artistic (1)
Author/Editor
Johannsson, Gudmundu ... (7)
Carlsson, B (2)
Wennergren, Göran, 1 ... (2)
Oscarsson, J. (2)
Jonasson, Jon (1)
Ljungqvist, Olle, 19 ... (1)
show more...
Lilja, Hans (1)
Ahren, B (1)
Johansson, A (1)
Jahnson, Staffan (1)
Svensson, J (1)
Ohlsson, K (1)
Janerot-Sjöberg, Bir ... (1)
Lindblad, Bengt (1)
Viale, G (1)
Bergström, R (1)
Ahrné, Siv (1)
Widerström, Micael, ... (1)
Adrian, Katrin, 1966 (1)
Lönn, L (1)
Hultberg, Björn (1)
Lindstedt, G (1)
Dehlin, Ove (1)
Hedin, G (1)
Björntorp, P (1)
Risberg, B (1)
Sjöström, Lars (1)
Wadell, Göran (1)
Juto, Per (1)
Bengtsson, Bengt-Åke ... (1)
Lindstedt, Göran, 19 ... (1)
Tidefelt, Ulf, 1951- (1)
Ask, Per (1)
Dahlbäck, Björn (1)
Kjellmer, Ingemar, 1 ... (1)
Bergenfelz, A (1)
Vessby, B (1)
Bosaeus, Ingvar, 195 ... (1)
Berglund, L. (1)
Rosberg, Sten, 1945 (1)
Venge, Per (1)
Axelsson, L. (1)
Johansson, Per, 1966 (1)
Wallengren, Joanna (1)
Becker, Charlotte (1)
Svensson, Torbjörn (1)
Nilsson, Åke (1)
Amin, Kawa, 1963- (1)
Sevéus, Lahja (1)
Lundberg, P A (1)
show less...
University
University of Gothenburg (11)
Örebro University (10)
Lund University (6)
Umeå University (2)
Uppsala University (2)
Linköping University (2)
show more...
Royal Institute of Technology (1)
show less...
Language
English (29)
Swedish (4)
Research subject (UKÄ/SCB)
Medical and Health Sciences (33)
Engineering and Technology (2)
Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view